Evaluation of the central and peripheral effects of doxepin on carrageenan-induced inflammatory paw edema in rat

Mohsen Zabihi Zabihi, Valiollah Hajhashemi, Mohsen Minaiyan, Ardeshir Talebi

Abstract


The anti-inflammatory effects of anti-depressants have been demonstrated recently. Doxepin, a tricyclic antidepressant drug (TCA), has some special properties in comparison with the other members of its family. It has some H1, H2, alpha-1 adrenergic and muscarinic receptor blocking effects. It revealed also                     anti-nociceptive and relatively potent sedative effects. This study was aimed to evaluate its possible anti-inflammatory effect in a well-established animal model. Male Wistar rats weighing 200-250 g were used in carrageenan-induced inflammatory paw edema model. The test and control drugs were injected by intraperitoneal (i.p.) and intracerebral (i.c.v.) routes. The anti-inflammatory activity of doxepin (15, 30 and 60 mg/kg, i.p. and 50 and 100 μg/rat, i.c.v.) and the reference drug, dexamethasone (2 mg/kg, i.p.) were evaluated by determination and comparison of some involved biological markers including the paw volume, cytokine levels (interleukin 6 (IL-6), IL-1β, tumor necrosis factor α (TNFα)), myeloperoxidase (MPO) activity and histopathological parameters. All i.p. doses of doxepin showed significant anti-inflammatory effect. It also significantly reduced MPO activity and cytokine levels and improved histopathologic parameters of carrageenan-injected paw tissues. I.c.v. administration of the drug did not show any significant reduction of carrageenan-induced paw edema. Although the exact mechanism of the anti-inflammatory effect of doxepin is not clear, it seems that reduced leukocyte migration and pro-inflammatory cytokines play important role in its anti-inflammatory effect. Also central sites are not involved in the anti-inflammatory effect of the drug.


Keywords


Anti-inflammatory; Carrageenan; Cytokines; Doxepin

Full Text:

PDF

References


Thase ME. Overview of antidepressant therapy. Manag Care. 2001;10(8 Suppl):6-9. Discussion 18-22.

Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet. 2003;361(9358):653-661.

Hajhashemi V, Minaiyan M, Banafshe HR, Mesdaghinia A, Abed A. The anti-inflammatory effects of venlafaxine in the rat model of carrageenan-induced paw edema. Iran J Basic Med Sci. 2015;18(7):654-8.

Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol. 2010;25(3):201-215.

Kostadinov I, Delev D, Petrova A, Stanimirova I, Draganova K, Kostadinova I, et al. Study on anti-inflammatory and immunomodulatory effects of clomipramine in carrageenan-and lipopolysaccharide-induced rat models of inflammation. Biotechno Biotechnol Equip. 2014;28(3):552-558.

Sadeghi H, Hajhashemi V, Minaiyan M, Movahedian A, Talebi A. Further studies on anti-inflammatory activity of maprotiline in carrageenan-induced paw edema in rat. Int Immunopharmacol. 2013;15(3):505-510.

Abdel-Salam OM, Nofal SM, El-Shenawy SM. Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res. 2003;48(2):157-165.

Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A. The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenaninduced paw edema in rats. Clinics (Sao Paulo). 2010;65:1183-1187.

Sadeghi H, Hajhashemi V, Minaiyan M, Movahedian A, Talebi A. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol. 2011;667(1-3):396-401.

Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009;58(3):367-378.

Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev.. 2011;10(8):CD003460.

Lyttle JR, Urquhart DM, Cicuttini FF, Wluka AE. Antidepressants for osteoarthritis. The Cochrane Library. 2016;893:393-397.

Saravanan V, Krishnaraju V. Comparative effect of antidepressants (duloxetine) and nsaid (dexibuprofen) in a new rat model of chronic pain induced depression associated with monosodium iodo acetate (mia) induced osteoarthritis in rats. Br J Pharm Res. 2014;4(1):113-124.

Wichniak A, Wierzbicka A, Jernajczyk W. Sleep and antidepressant treatment. Curr Pharm Des. 2012;18(36):5802-5817.

Negro-Alvarez JM, Carreno-Rojo A, Funes-Vera E, Garcia-Canovas A, Abellan-Aleman AF, Rubio del Barrio R. Pharmacologic therapy for urticaria. Allergol Immunopathol. 1997;25(1):36-51.

Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med. 1996;156(10): 1047-1052.

Sansone RA, Sansone LA. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont). 2008;5(12):16-19.

Wrzosek A, Obara I, Wordliczek J, Przewlocka B. Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis. J Physiol Pharmacol. 2009;60(4):71-78.

Shibuya K, Funaki Y, Hiraoka K, Yoshikawa T, Naganuma F, Miyake M, et al. [(11)C]Doxepin binding to histamine H1 receptors in living human brain: reproducibility during attentive waking and circadian rhythm. Front Syst Neurosci. 2012;6:45.

Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475(7354):65-70.

Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci. 2001;26:21-29.

Singh H, Becker PM. Novel therapeutic usage of low-dose doxepin hydrochloride. Expert opin investig drugs. 2007;16(8):1295-1305.

Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A. Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats. Inflamm Res. 2010;59(12):1053-1059.

Budantsev A, Kisliuk OS, Shul'govskii VV, Rykunov DS, Iarkov AV. [The brain in stereotaxic coordinates (a textbook for colleges)]. Zh Vyssh Nerv Deiat Im I P Pavlova. . 1993;43(5):1045-1051.

Winter CA, RisLey EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544-547.

Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206-209.

Di Rosa M, Giroud JP, Willoughby DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971;104(1):15-29.

Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol.. 2003;225:115-121.

Al-Haboubi HA, Zeitlin IJ. Re-appraisal of the role of histamine in carrageenan-induced paw oedema. Eur J Pharmacol. 1983;88(2-3):169-176.

Je I-G, Kim H-H, Park P-H, Kwon TK, Seo S-Y, Shin T-Y, et al. SG-HQ2 inhibits mast cell-mediated allergic inflammation through suppression of histamine release and pro-inflammatory cytokines. Exp Biol Med (Maywood). 2015;240(5):631-638.

Shajib MS, Khan WI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf). 2015;213(3): 561-574.

Verbout NG, Jacoby DB. Muscarinic receptor agonists and antagonists: effects on inflammation and immunity. Handb Exp Pharmacol. 2012;(208):403-27.

Frahnert C, Rao ML, Grasmäder K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J Chromatogr B Analyt Technol Biomed Life Sci. . 2003;794(1):35-47.

Gronewold A, Dettling A, Haffner HT, Skopp G. Doxepin and nordoxepin concentrations in body fluids and tissues in doxepin associated deaths. Forensic Sci Int. 2009;190(1-3):74-79.

Shu YZ, Hubbard JW, Cooper JK, McKay G, Korchinski ED, Kumar R, et al. The identification of urinary metabolites of doxepin in patients. Drug Metab Dispos. 1990;18(5):735-741.

Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav Immun. 2002;16(5): 569-574.

Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A. Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites. Iran J Pharm Res. 2011;10(3):611-618.

Gądek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 2013;65(6):1655-1662.


Refbacks

  • There are currently no refbacks.